Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.
Hoskin P, Lee M, Dunkley D, Danh M, Wickens R, Saunders G, Northey J, Crabb S, McFarlane V, Sadozye A, Cooper R, Mathew T, Haslett K, Reeves K, Reed R, Bigos K, Williams KJ, Rowling E, Choudhury A, Dancer S, Smith D, Griffiths G.
Hoskin P, et al. Among authors: smith d.
BMC Cancer. 2024 Jun 7;24(1):702. doi: 10.1186/s12885-024-12310-w.
BMC Cancer. 2024.
PMID: 38849715
Free PMC article.
Clinical Trial.